Key result
Statin intensity and sex are associated with distinct carotid plaque lipidomic profiles.
Why the study?
Carotid atherosclerosis is a major risk factor for ischemic stroke, and plaque lipidomics may complement clinical assessment by providing biochemical insight into plaque heterogeneity and its associations with risk factors and therapy.
Does lipid-lowering therapy and clinical characteristics alter the carotid plaque lipidomic profile in patients undergoing carotid endarterectomy?
Cohort (n=82)
Does lipid-lowering therapy and clinical characteristics alter the carotid plaque lipidomic profile in patients undergoing carotid endarterectomy?
Carotid plaque lipidomic composition varies significantly by patient sex, cardiovascular comorbidities, and statin therapy intensity, offering biochemical insight into plaque heterogeneity.
Answers are grounded in this paper and cite their sources.
Carotid plaque lipidomes differ by sex and therapy; extends molecular characterization of atherosclerosis while leaving clinical utility open.
Background Carotid atherosclerosis is a major risk factor for ischemic stroke. Plaque lipidomics may complement clinical assessment by providing biochemical insight into plaque heterogeneity and associations with risk factors and therapy. Methods Patients undergoing carotid endarterectomy between 2020 and 2023 (age 18–90 years) were included. Plaques were excised en bloc, snap‐frozen, sectioned, and analyzed by UHPLC–HRMS. A representative lipidomic profile per patient was calculated as the median across plaque sections. Associations with clinical characteristics and lipid‐lowering therapy intensity were assessed using univariate testing, ANOVA, correlation analysis, and decision‐tree models. Results The cohort comprised 82 patients. Sex showed the strongest lipidomic signal, with higher plasmalogen abundance in plaques from female patients and higher ceramides, diacylglycerols, and triacylglycerols in plaques from male patients. Hypertension was associated with increased sphingolipids and reduced plasmalogens, whereas diabetes mellitus showed differences across multiple lipid classes (e.g., cholesteryl esters, lysophosphatidylcholines, plasmalogen phospholipids, and sphingomyelin). Lipid‐lowering therapy intensity was associated with distinct lipidomic patterns, with higher levels of selected cholesteryl esters in patients without statin therapy and more prominent ether‐linked TAGs and plasmalogen phospholipids in high‐intensity statin users. Conclusions Carotid plaque lipidomic composition is associated with clinical characteristics and lipid‐lowering therapy, capturing biologically meaningful heterogeneity of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Seidlová et al. (2026) conducted a cohort in Carotid atherosclerosis (n=82). Clinical characteristics (sex, hypertension, diabetes) and lipid-lowering therapy intensity vs. Different clinical strata and patients without statin therapy was evaluated on Carotid plaque lipidomic composition analyzed by UHPLC–HRMS. Clinical characteristics (especially sex) and statin intensity were associated with distinct carotid plaque lipidomic profiles in 82 endarterectomy patients.
Synapse has enriched 10 related papers. Consider them for comparative context: